Covis Announces Commencement Of $13.75/shr Tender Offer To Acquire AMAG - Quick Facts
(RTTNews) - Covis Group S.à r.l. announced the commencement of a cash tender offer to purchase all of the outstanding shares of common stock of AMAG Pharmaceuticals, Inc. (AMAG). The deal has a total enterprise value of approximately $647 million, including net debt. The tender offer will expire on November 12, 2020.
Covis is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It is headquartered in Luxembourg with operations in Zug, Switzerland.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.